Kamada Ltd
NASDAQ:KMDA

  • LAST PRICE
    5.7970
  • TODAY'S CHANGE (%)
    -0.0730 (-1.2436%)
  • Bid / Lots
    5.7800/ 7
  • Ask / Lots
    5.8200/ 7
  • Open / Previous Close
    5.8300 / 5.8700
  • Day Range
    5.7100
    5.8300
  • 52 Week Range
    4.6000
    6.5291
  • Volume
    27,948

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 14, 2024

  • Nov 13, 2024

      Show headlines and story abstract

    • 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
      Companies Mentioned: KMDA
      net 6 (144) 17 (104) (125) ------- ------- ------ ------- ------- 14,744 14,360 4,926 4,532 15,678 ------- ------- ------ ------- ------- Changes in asset and liability items: Decrease (increase) in trade receivables, net 3,249 2,078 10,004 (618) 7,835 Decrease (increase) in other accounts receivables 1,452 2,716 510 1,177 (1,150) Decrease (increase) in inventories 16,920 (5,011) 7,155 6,441 (19,694) Decrease (increase) in deferred expenses 336 2,763 97 (279) 2,814 Decrease in trade payables (10,747) (18,617) (5,655) (13,181) (8,885) Increase (decrease) in other accounts payables (157) (359) 881 49 765 Increase (decrease) in deferred revenues (107) (20) 14 (23) 113 ------- ------- ------ ------- ------- 10,946 (16,450) 13,006 (6,434) (18,202) ------- ------- ------ ------- ------- Cash received (paid) during the period for: Interest paid (424) (1,149) (158) (405) (1,228) Interest received 1,434 92 646 67 - Taxes paid (158) (174) (70) (62) (217) ------- ------- ------ ------- ------- 852 (1,231) 418 (400) (1,445) ------- ------- ------ ------- ------- Net cash provided by (used in) operating activities $ 37,196 $ (95) $22,213 $ 921 $ 4,315 -------------- ------- ------- ------ ------- -------

    • 7:00AM ET on Wednesday Nov 13, 2024 by Dow Jones
      Companies Mentioned: KMDA
      net 6 (144) 17 (104) (125) ------- ------- ------ ------- ------- 14,744 14,360 4,926 4,532 15,678 ------- ------- ------ ------- ------- Changes in asset and liability items: Decrease (increase) in trade receivables, net 3,249 2,078 10,004 (618) 7,835 Decrease (increase) in other accounts receivables 1,452 2,716 510 1,177 (1,150) Decrease (increase) in inventories 16,920 (5,011) 7,155 6,441 (19,694) Decrease (increase) in deferred expenses 336 2,763 97 (279) 2,814 Decrease in trade payables (10,747) (18,617) (5,655) (13,181) (8,885) Increase (decrease) in other accounts payables (157) (359) 881 49 765 Increase (decrease) in deferred revenues (107) (20) 14 (23) 113 ------- ------- ------ ------- ------- 10,946 (16,450) 13,006 (6,434) (18,202) ------- ------- ------ ------- ------- Cash received (paid) during the period for: Interest paid (424) (1,149) (158) (405) (1,228) Interest received 1,434 92 646 67 - Taxes paid (158) (174) (70) (62) (217) ------- ------- ------ ------- ------- 852 (1,231) 418 (400) (1,445) ------- ------- ------ ------- ------- Net cash provided by (used in) operating activities $ 37,196 $ (95) $22,213 $ 921 $ 4,315 -------------- ------- ------- ------ ------- -------

  • Nov 6, 2024

  • Nov 4, 2024

      Show headlines and story abstract

    • 7:00AM ET on Monday Nov 04, 2024 by Dow Jones
      Companies Mentioned: KMDA

      Kamada to Present at the Stifel 2024 Healthcare Conference

      REHOVOT, Israel and HOBOKEN, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will present a corporate overview at the Stifel 2024 Healthcare Conference, which will take place in New York, NY, on November 18 - 19, 2024.

Peers Headlines